TY - JOUR
T1 - The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up
AU - Cardaba, Blanca
AU - San-José, María Esther
AU - Sánchez-Diez, Silvia
AU - Sastre, Joaquin
AU - Barranco, Pilar
AU - Bobolea, Irina
AU - Cruz, María Jesús
AU - Mullol, Joaquim
AU - Plaza, Vicente
AU - Ramos, David
AU - Fernandez-Nieto, María del Mar
AU - Sastre, Beatriz
AU - Valero, Antonio
AU - Ausín, María del Pilar
AU - Quirce, Santiago
AU - Cañas, Jose Antonio
AU - del Pozo, Victora
AU - Olaguibel, José María
AU - Soto, Lorena
AU - Álvarez-Puebla, María José
AU - Arochena, Lourdes
AU - Salgado, Francisco Javier
AU - Muñoz, Xavier
AU - Giner, Jordi
AU - Ojanguren, Iñigo
AU - Luna, Juan Alberto
AU - Rial, Manuel
AU - Torrejón, Montserrat
AU - Romero-Mesones, Christian
AU - Domínguez-Ortega, Javier
AU - Picado, César
AU - González-Barcala, Francisco Javier
AU - Urnadoz, Marisa
AU - Valdes, Luis
AU - Arismendi, Ebymar
AU - Crespo, Astrid
PY - 2018/7/1
Y1 - 2018/7/1
N2 - © 2018 SEPAR The general aim of this study is to create a cohort of asthma patients with varying grades of severity in order to gain greater insight into the mechanisms underlying the genesis and course of this disease. The specific objectives focus on various studies, including imaging, lung function, inflammation, and bronchial hyperresponsiveness, to determine the relevant events that characterize the asthma population, the long-term parameters that can determine changes in the severity of patients, and the treatments that influence disease progression. The study will also seek to identify the causes of exacerbations and how this affects the course of the disease. Patients will be contacted via the outpatient clinics of the 8 participating institutions under the auspices of the Spanish Respiratory Diseases Networking System (CIBER). In the inclusion visit, a standardized clinical history will be obtained, a clinical examination, including blood pressure, body mass index, complete respiratory function tests, and FENO will be performed, and the Asthma Control Test (ACT), Morisky-Green test, Asthma Quality of Life Questionnaire (Mini AQLQ), the Sino-Nasal Outcome Test 22 (SNOT-22), and the Hospital Anxiety and Depression scale (HADS) will be administered. A specific electronic database has been designed for data collection. Exhaled breath condensate, urine and blood samples will also be collected. Non-specific bronchial hyperresponsiveness testing with methacholine will be performed and an induced sputum sample will be collected at the beginning of the study and every 24 months. A skin prick test for airborne allergens and a chest CT will be performed at the beginning of the study and repeated every 5 years.
AB - © 2018 SEPAR The general aim of this study is to create a cohort of asthma patients with varying grades of severity in order to gain greater insight into the mechanisms underlying the genesis and course of this disease. The specific objectives focus on various studies, including imaging, lung function, inflammation, and bronchial hyperresponsiveness, to determine the relevant events that characterize the asthma population, the long-term parameters that can determine changes in the severity of patients, and the treatments that influence disease progression. The study will also seek to identify the causes of exacerbations and how this affects the course of the disease. Patients will be contacted via the outpatient clinics of the 8 participating institutions under the auspices of the Spanish Respiratory Diseases Networking System (CIBER). In the inclusion visit, a standardized clinical history will be obtained, a clinical examination, including blood pressure, body mass index, complete respiratory function tests, and FENO will be performed, and the Asthma Control Test (ACT), Morisky-Green test, Asthma Quality of Life Questionnaire (Mini AQLQ), the Sino-Nasal Outcome Test 22 (SNOT-22), and the Hospital Anxiety and Depression scale (HADS) will be administered. A specific electronic database has been designed for data collection. Exhaled breath condensate, urine and blood samples will also be collected. Non-specific bronchial hyperresponsiveness testing with methacholine will be performed and an induced sputum sample will be collected at the beginning of the study and every 24 months. A skin prick test for airborne allergens and a chest CT will be performed at the beginning of the study and repeated every 5 years.
KW - Phenotype
KW - Eosinophilic asthma
KW - Fixed airflow obstruction
KW - Biomarkers
KW - Epigenetics
KW - Exacerbations
KW - Bronchiectasis
KW - Neutrophilic asthma
UR - https://dialnet.unirioja.es/servlet/articulo?codigo=6489978
U2 - 10.1016/j.arbres.2017.12.012
DO - 10.1016/j.arbres.2017.12.012
M3 - Article
SN - 0300-2896
VL - 54
SP - 378
EP - 385
JO - Archivos de Bronconeumologia
JF - Archivos de Bronconeumologia
IS - 7
ER -